Organization Overview
Alternative names
belantamab mafodotin (TECVAYLI) (1 trial)
cabozantinib (cometriq) (1 trial)
carboplatin (paraplatin) (1 trial)
daratumumab (darzalex) (2 trials)
elotuzumab (empliciti) (1 trial)
hyaluronidase (human recombinant) (Hylenex) (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
Acute Pain (Phase 4)
Alopecia (Phase 2)
Alopecia Areata (Phase 2)
Amyotrophic Lateral Sclerosis (Phase 1)
Emergencies (Phase 4)
Extensively Drug-Resistant Tuberculosis (Phase 3)
Glioblastoma (Phase 1)
Glioma (Phase 2)
Graft vs Host Disease (Phase 2)
Infections (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Melanoma (Phase 2)
Motor Neuron Disease (Phase 1)
Multiple Myeloma (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Pancreatic Diseases (Phase 3)
Pancreatic Neoplasms (Phase 3)
Sclerosis (Phase 1)
Tuberculosis (Phase 3)
Tuberculosis, Multidrug-Resistant (Phase 3)
Tuberculosis, Pulmonary (Phase 3)
Urinary Retention (Phase 2)